Phenylacetic acid
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
834 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | 11 | 25 | 51 | 92 | 42 | 211 |
| Hyperkinesis | D006948 | — | — | 4 | 14 | 29 | 47 | 30 | 118 |
| Pain | D010146 | EFO_0003843 | R52 | 5 | 7 | 6 | 17 | 10 | 45 |
| Healthy volunteers/patients | — | — | — | 25 | 1 | 2 | 4 | 11 | 43 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | 9 | 9 | 6 | 7 | 31 |
| Postoperative pain | D010149 | — | G89.18 | 2 | 3 | 5 | 5 | 10 | 24 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | 1 | 7 | 5 | 3 | 4 | 19 |
| Cocaine-related disorders | D019970 | — | F14 | 7 | 7 | 1 | 1 | 1 | 16 |
| Neoplasms | D009369 | — | C80 | 1 | 5 | 7 | 1 | 2 | 14 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | 3 | 5 | 3 | 13 |
Show 203 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fatigue | D005221 | — | R53.83 | 2 | 9 | 11 | — | 1 | 20 |
| Prostatic neoplasms | D011471 | — | C61 | — | 7 | 1 | — | — | 7 |
| Inflammation | D007249 | MP_0001845 | — | 3 | 1 | 1 | — | 1 | 6 |
| Hepatic encephalopathy | D006501 | — | K72.91 | 1 | 3 | 1 | — | — | 5 |
| Central nervous system neoplasms | D016543 | — | — | — | 4 | 1 | — | — | 5 |
| Brain diseases | D001927 | — | G93.40 | 1 | 2 | 1 | — | — | 4 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | 2 | 2 | — | — | 4 |
| Sclerosis | D012598 | — | — | 1 | 2 | 2 | — | — | 4 |
| Tendinopathy | D052256 | EFO_1001434 | M77.9 | — | 1 | 1 | — | 2 | 3 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | 2 | 1 | — | — | 3 |
Show 54 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Impulsive behavior | D007175 | — | — | 2 | 1 | — | — | 2 | 5 |
| Alcohol drinking | D000428 | EFO_0004329 | — | 2 | 2 | — | — | — | 4 |
| Astrocytoma | D001254 | EFO_0000271 | — | — | 4 | — | — | — | 4 |
| Glioma | D005910 | EFO_0000520 | — | — | 4 | — | — | — | 4 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 4 | — | — | — | 4 |
| Lymphoma | D008223 | — | C85.9 | — | 4 | — | — | — | 4 |
| Liver failure | D017093 | — | K72.9 | 1 | 1 | — | — | 1 | 3 |
| Hepatic insufficiency | D048550 | — | — | 1 | 1 | — | — | 1 | 3 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | — | 3 | — | — | — | 3 |
| Smoking | D012907 | EFO_0004318 | — | — | 3 | — | — | — | 3 |
Show 83 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Borderline personality disorder | D001883 | — | F60.3 | 1 | — | — | — | 2 | 3 |
| Edema | D004487 | — | R60.9 | 1 | — | — | — | 1 | 2 |
| Pure autonomic failure | D054970 | — | — | 2 | — | — | — | — | 2 |
| Uveitis | D014605 | EFO_1001231 | H20.9 | 1 | — | — | — | 1 | 2 |
| Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
| Hypotension | D007022 | EFO_0005251 | I95 | 1 | — | — | — | — | 1 |
| Orthostatic hypotension | D007024 | — | I95.1 | 1 | — | — | — | — | 1 |
| Aging | D000375 | GO_0007568 | R41.81 | 1 | — | — | — | — | 1 |
| Inborn urea cycle disorders | D056806 | — | E72.2 | 1 | — | — | — | — | 1 |
| Carpal tunnel syndrome | D002349 | EFO_0004143 | G56.0 | 1 | — | — | — | — | 1 |
Show 18 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 2 | 2 |
| Motor activity | D009043 | EFO_0003940 | — | — | — | — | — | 2 | 2 |
| Rib fractures | D012253 | — | — | — | — | — | — | 2 | 2 |
| Retinal diseases | D012164 | — | H35.9 | — | — | — | — | 2 | 2 |
| Diabetic retinopathy | D003930 | EFO_0003770 | — | — | — | — | — | 2 | 2 |
| Intervertebral disc displacement | D007405 | EFO_1001800 | — | — | — | — | — | 2 | 2 |
| Neuralgia | D009437 | EFO_0009430 | — | — | — | — | — | 2 | 2 |
| Cataract extraction | D002387 | — | — | — | — | — | — | 2 | 2 |
| Endoscopic retrograde cholangiopancreatography | D002760 | — | — | — | — | — | — | 2 | 2 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 1 | 1 |
Show 75 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Phenylacetic acid |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use